Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -8.06% 2.85p 2.70p 3.00p 3.10p 2.65p 3.10p 1,584,815 11:30:44
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 0.9 -3.4 -2.9 - 5.17

Microsaic (MSYS) Latest News

More Microsaic News
Microsaic Takeover Rumours

Microsaic (MSYS) Share Charts

1 Year Microsaic Chart

1 Year Microsaic Chart

1 Month Microsaic Chart

1 Month Microsaic Chart

Intraday Microsaic Chart

Intraday Microsaic Chart

Microsaic (MSYS) Discussions and Chat

Microsaic Forums and Chat

Date Time Title Posts
20/1/201811:36Microsaic Systems - 20111,313
03/1/201807:33Microsaic - miniaturised chip-size scientific instruments10

Add a New Thread

Microsaic (MSYS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Microsaic trades in real-time

Microsaic (MSYS) Top Chat Posts

DateSubject
21/1/2018
08:20
Microsaic Daily Update: Microsaic is listed in the Software & Computer Services sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic was 3.10p.
Microsaic has a 4 week average price of 2.53p and a 12 week average price of 0.85p.
The 1 year high share price is 4.75p while the 1 year low share price is currently 0.85p.
There are currently 181,365,146 shares in issue and the average daily traded volume is 1,304,405 shares. The market capitalisation of Microsaic is £5,168,906.66.
20/1/2018
11:36
moneymunch: 28/9/17 OUTLOOK The Board sees significant opportunities for its MS instruments being integrated into multiple areas of bioprocessing, and for diagnostics in the longer term. The Company is transforming the way it operates. It has a vision to help solve some of the major problems in human health. To do this, the Company aims to work with global partners with similar aspirations, which are prepared to co-fund R&D development costs and ensure that new product opportunities are adequately validated so they meet customer needs. The Company expects its full year 2017 revenue to be significantly lower than 2016. The shortfall in revenue is expected to be off-set by lower overheads as a result of cost reduction plans implemented in H1 2017 and that the full year loss before tax will be broadly in line with 2016. Progress has been made in addressing the difficult trading conditions and H2 2017 revenues are anticipated to be above H1 2017 based on current Q3 performance. htTps://uk.advfn.com/stock-market/london/microsaic-MSYS/share-news/Microsaic-Systems-plc-Interim-Results/75741969
20/1/2018
10:34
bobmonkeyhouse: HOw does a falling share price look good? Have you sold when ramping again?
05/1/2018
15:16
moneymunch: Every chance we could get a positive trading statement/update soon on H2 2017 revenues and developments to add further value. Gla ;-) 28/9/17 "H2 2017 revenues from instruments and consumables are anticipated to be above H1 2017 based on current performance in Q3. " Technological enhancements The Company has a compelling product development pipeline in support of its bioprocessing applications and in maintaining its leading position in miniaturised MS instruments and technologies. Such enhancements aim to further extend the mass range for biologics detection, and introduce new capabilities, such as on-line desalting, which allows for the purification of biomolecules in real time. In doing so, analysis times can be reduced from weeks to hours, which offers the potential for significant savings in operational costs of bioprocessing. The Company has also developed a working prototype of a miniaturised "triple quadrupole" instrument, and is welcoming interest from partners for further product development and channels to market for this technology, in life science applications. Traditional markets The Company is committed to working with its current OEM partners in small molecule detection. These partnerships provide important insights about customer needs and technology enhancements, as well as the capabilities and robustness of the Company's MS instruments in a real-world environment. Although H1 2017 was a very challenging period for revenues we are pleased to see these increasing again through continued close relationships with our partners. H2 2017 revenues from instruments and consumables are anticipated to be above H1 2017 based on current Q3 performance. hTtps://uk.advfn.com/stock-market/london/microsaic-MSYS/share-news/Microsaic-Systems-plc-Interim-Results/75741969
03/1/2018
07:33
bmwman3: Massive confidence of share price shown with the options granted and yet more tightly held shares!
03/1/2018
07:02
moneymunch: Microsaic Systems Award of Options RNS Number : 7779A Microsaic Systems plc 03 January 2018 Microsaic Systems plc Award of options Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry ("MS") instruments designed to improve the efficiency of pharmaceutical R&D, announces that on 2 January 2018, the Company awarded options ("New Options") to directors and employees over 9,000,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares"), representing approximately 4.96% of the issued share capital of the Company. Options have been granted to directors as detailed below: The 3,500,000 New Options awarded to Peter Grant, Non-Executive Chairman were awarded under the Company's Unapproved Share Option Scheme and have an exercise price of 4.05 pence per Ordinary Share being the closing share price on 29 December 2017. These options are subject to performance criteria as well as not being ordinarily exercisable prior to the third anniversary of the date of award. The 2,000,000 New Options awarded to the executive directors ("Management Options") were awarded under Microsaic's Enterprise Management Incentive (EMI) Scheme. The Management Options have an exercise price of 4.05 pence per Ordinary Share, being the closing share price on 29 December 2017. These options are subject to performance criteria as well as not being ordinarily exercisable prior to the third anniversary of the date of award. The balance of 3,500,000 New Options were awarded to all other employees of the Company ("Employee Options") under Microsaic's EMI Scheme. The Employee Options have an exercise price of 4.05 pence per Ordinary Share, being the closing share price on 29 December 2017. These options are not subject to performance criteria but are subject to not being ordinarily exercisable prior to the third anniversary of the date of award. Following the award of the New Options, the total number of Ordinary Shares outstanding under share incentive scheme arrangements is 14,447,200 representing 7.97% of the Company's issued share capital.
28/12/2017
08:22
jungmana: I think right now a share price of triple todays (10 to 12p )would be fair valuation.Lots of key drivers in 2018 and this could easily get to 30p+
21/12/2017
13:22
jungmana: 3p paid. Just the start. This was a big tip at 17p todays share price equivalent just 2 years back.And look at the progress since
21/12/2017
12:27
jungmana: Now back to MSYS;£5m market cap right now. £3m+ in cash and the story is just compelling.2 years back this was tipped as a buy at £30m market cap. Thats about 17p share price today
17/12/2017
11:18
kingston78: What is more significant from a technical perspective is that the chart has now broken the long term downtrend. The scope of an upward rise is phenomenal. In due course it has the capability of reclaiming the lost ground back in April 2015 when the share price was at 50 p. I expect a very short term target of 10 p and then 20 p within three months. By way of comparison, PYC rose from 1 p to 30 p within a week before stabilising at around 11 p. VAL went up from under 1 p to 7 p in short order. There is no reason why MSYS could not do the same.
27/8/2016
10:12
maytrees: johnwall Many thanks - I do appreciate the risks of AIM but this co has been quiet for some time so it was disappointing that their latest RNS apart from providing the latest a/cs announced the placing. Also look at the share price graph above - some AIM companies SPs do head N on occasion. Then there is the tiny number of shares that MMs permit investors to buy/sell at the specified share price Any sells above that number are at well below published bid share price The company has hardly been informative in the previous RNS either. What was the following June RNS about? 20 June 2016 Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that at its Annual General Meeting held on 20 June 2016 ("AGM"), ordinary resolutions 1 to 8 were passed. Resolution 9, a special resolution regarding disapplication of pre-emption rights, was withdrawn by the Directors prior to commencement of the AGM. Previously there had been much progress reported but yet another rights issue. Before that there had been a positive announcement that: Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, announces an improved business performance in the six months to 31 December 2015. The Company sold seventeen 4000 MiD® units in H2 2015 versus six units in H1 2015. The Board anticipates that sales for H1 2016 will continue this positive trend. The Company is pleased to announce that it has also signed a new distributor agreement for the 4000 MiD®; details of which will be provided in the 2015 Annual Report. Then share options granted along the lines of: These share options were granted under the Microsaic Systems Enterprise Management Incentive Scheme with an exercise price of 23.5 pence per ordinary share, being the closing mid-market price of the Company's shares on 12 January 2016. The options granted to Mr Ramage will vest on 1 January 2017. Gave ordinary PIs imho grounds for assuming that by September 2016 the co's share price would not be at an all time low. Frankly a little more realism would have been more apt I sold half my holding at a loss and sadly am far from convinced that the other half will ever show blue - happy to be proved wrong of course.
Microsaic share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180121 12:28:15